Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
R. Luo et al. / Journal of Catalysis 287 (2012) 170–177
171
center, the amphiphilic polyether-long chain, and the hydrophilic
IL linker. We envisage that the amphipathic nature of the PEG
chain can allow PEG-based catalysts to undergo inherent phase
transfer, which is in turn expected to increase the reaction rates
in two-phase systems. Furthermore, the solubility properties of
the PEG, that is, it is soluble in CH2Cl2, but can be precipitated with
n-hexane, potentially endow the novel complexes with the feature
of solvent-regulated separation.
ion spray voltage, 8 psi for curtain gas, 8 psi for drying gas heated
to 100 °C, 7 psi for nebulizing gas, respectively. The optical rotation
of catalysts was measured in dichloromethane on a WZZ-2A Auto-
matic Polarimeter. The conversions and the ee values were mea-
sured by a 6890 N gas chromatograph (Agilent Co.) equipped
with the chiral capillary column (HP19091G-B213, 30 m ꢁ
0.32 mm ꢁ 0.25
lm) and the FID detector.
Herein, the N-polyether-substituted imidazol was synthesized
and successfully introduced into the two sides of 5,50 positions in
the salen ligand of (R,R)-{N-(3-tert-butyl-5-chloromethyl-salicyli-
dine)-N0-(30-tert-butyl-50-chloromethyl-salicylidine)}-1,2-cyclo-
hexanediamine, which provided the imidazolium IL containing
polyether chain functionalized chiral salen Mn(III) complex (PICC).
It has proved that the new catalysts could achieve the process of
phase-transfer catalysis (PTC) in the asymmetric epoxidation of
unfunctionalized olefins using NaOCl as an oxidant and could be
facilely separated for reuse by control of the solvent. Thus, the
problems associated with the phase-transfer limitation in the bi-
phasic reaction and the separation of the catalysts can be well re-
solved. In addition, the total length of polyether chain significantly
affected the catalytic performances of the novel complexes.
2.3. Preparation of PICC-n (n = 5, 15, 25)
The preparation of PICC-n (n = 5, 15, 25) was outlined in
Scheme 1.
2.3.1. Synthesis of N-polyoxyethyleneimidazole A
Frozen imidazole (1.7 g, 25 mmol) and n-hexane (15 mL) were
added into an autoclave (100 mL). Different amount of the frozen
ethylene oxide liquid (EO, 10 mL for n = 5; 20 mL for n = 15;
30 mL for n = 25) was subsequently added into the autoclave with
a magnetic stirrer. The resulted mixture was kept at room temper-
ature under N2 overnight, and then stirred for 5 h at 60 °C. After
removing solvent, the mixture was dried under vacuum to afford
the compound A as a dark brown viscous liquid. The average num-
bers of ethylene oxide unit of the polyether chain were calculated
from the weight increase of products [33]. Compound A (n = 15):
1HNMR (D2O, 500 MHz) dH, ppm: 7.65 (s, 1H, ring NCHN), 7.15
(s, 1H, ring C@NCH), 6.96 (s, 1H, ring NAC@CH), 4.15 (t, 2H,
J = 10 Hz, OACH2ACH2ANring), 3.55–3.63 (m, 58H, H(OAC2H4AO)14
2. Experimental
2.1. Materials and reagents
( )-1,2-diaminocyclohexane and 3-chloroperoxybenzoic acid
(m-CPBA) were purchased from Alfa Aesar. Indene and 1,2-dihy-
dronaphthalene were obtained by TCI. Pyridine-N-oxide (PyNO)
was bought from Aldrich. Other commercially available chemicals
were laboratory grade reagents from local suppliers. All of the sol-
vents were purified by standard procedures [27]. Styrene and in-
dene were passed through a pad of neutral alumina before use.
6-cyano-2,2-dimethylchromene and 6-nitro-2,2-dimethylchrom-
ene were synthesized according to the literature procedures [28].
[(R,R0)-(N,N0-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanedi-
aminato] manganese(III) chloride (the neat complex) was prepared
according to the procedures described in Ref. [29]. 3-tert-butyl-2-
hydroxybenzaldehyde and 3-tert-butyl-5-chloromethyl-2-hydroxy
benzaldehyde were prepared according to the procedures de-
scribed in Refs. [30,31], respectively.
CH2). FT-IR (KBr): c
max/cmꢀ1 3369, 2871, 1655, 1510, 1455, 1351,
1291, 1249, 1107, 947, 887, 833, 747, 668, 626.
2.3.2. Synthesis of modified salicylaldehyde B
N-polyoxyethylene imidazole A (10 mmol) in dry benzene
(20 mL) was added dropwise into the benzene solution of 3-tert-
butyl-5-chloromethylsalicylaldehyde (10 mmol, 2.27 g) under stir-
ring. The obtained mixture was refluxed for 48 h. After the comple-
tion of the reaction, the lower viscous liquid was washed three
times with dry benzene. The solvent was removed to obtain the
compound B as the dark brown viscous liquids. Compound B
(n = 15): 1HNMR (D2O, 500 MHz) dH, ppm: 9.76 (s, 1H, CH@O),
7.48–7.60 (m, 5H, ring NCH and ArH), 5.33 (s, 2H, ArACH2ANring)),
4.34 (t, 2H, J = 9.8 Hz, OACH2ACH2ANring), 3.48–3.82 (m, 58H,
H(OAC2H4AO)14CH2), 1.11–1.28 (s, 9H, t-butyl). FT-IR (KBr): cmax
/
2.2. Methods
cmꢀ1 3378, 2948, 2873, 1647, 1560, 1440, 1351, 1390, 1323,
1272, 1238, 1213, 1188, 1106, 946, 887, 835, 775, 705, 528.
FT-IR spectra were obtained as potassium bromide pellets with
a resolution of 4 cmꢀ1 and 32 scans in the range 400–4000 cmꢀ1
using an AVATAR 370 Thermo Nicolet spectrophotometer. The
ultraviolet–visible light (UV–vis) spectra were recorded on a
UV–vis Agilent 8453 spectrophotometer. The solution of samples
in dichloromethane (ca. 1.0 mM) was poured into a 1 cm quartz
cell for UV–vis adsorption with dichloromethane as the reference.
The thermogravimetric and differential thermogravimetric
(TG–DTG) curves were obtained on a NETZSCH STA 449C thermal
analyzer. Samples were heated from room temperature up to
700 °C under flowing air using alumina sample holders. The sample
weight was ca. 10 mg and the heating rate was 10 K/min. 1HNMR
spectra of samples were recorded on a Varian-500 spectrometer
with TMS as an internal standard. Thin layer chromatography
2.3.3. Synthesis of the PEG-IL-functionalized chiral salen ligand (PICL)
(1R, 2R)-(ꢀ)-1, 2-diaminocyclohexane mono-(+)-tartrate salt
(2.5 mmol, 0.660 g) was treated with saturated potassium hydrox-
ide (5.0 mmol, 0.280 g) in 20 mL dichloromethane under vigor-
ously stirring at room temperature. The resulted cloudy mixture
was stirred for another 2 h. The liberated diamine was dried over
anhydrous Na2SO4. After removal of the solvent in vacuum, the
(1R, 2R)-(ꢀ)-1, 2-diaminocyclohexane was dissolved in anhydrous
ethanol and added dropwise into the solution of PEG-IL modified
salicylaldehyde B (5 mmol) in anhydrous ethanol (10 mL) at room
temperature. The resulting mixture was refluxed for another 8 h to
synthesize the PEG-IL-functionalized chiral salen ligand (PICL).
PICL (n = 15): 1H NMR (D2O, 500 MHz): dH, ppm: 8.35 (s, 2H,
CH@N), 7.02–7.57 (s, 10H, ring NCH and ArH), 5.42 (s, 4H,
ArACH2ANring), 4.60 (m, 4H, OACH2ACH2ANring), 3.66–3.91
(m, 116H, H(OAC2H4AO)14CH2), 3.60–3.62 (m, 2 H, C@NCH),
1.44–1.83 (m, 8H, cyclohexyl-H), 1.20–1.28 (s, 18H, t-butyl). FT-
(TLC) was conducted on glass plates coated with silica gel GF254
.
Mn ion contents were measured by the method of complexometry
with ethylenediamine tetraacetic acid (EDTA) according to Ref.
[32]. Mass spectrometry analyses were performed using an API
3000 tandem mass spectrometer (Applied Biosystems, USA) with
electrospray interface (ESI-MS/MS in MeOH). The operating condi-
tions in positive ionization mode were optimized using a +5500 V
IR (KBr):
1211, 1105, 942, 842, 776, 649.
c
max/cmꢀ1 3341, 2941, 2868, 1629, 1445, 1353, 1246,